Rate per 100,000 Population of Reported Cases by Age Group - 2009

Disease < 1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 1.5 0.0 0.0 0.4 1.4 6.3 14.3 13.7 9.8 2.5 6.7
Amebiasis 0.0 0.6 1.5 1.9 1.9 1.6 1.6 1.3 1.1 0.6 1.3
Babesiosis 0.8 0.0 0.2 0.1 0.0 0.5 1.7 2.1 2.8 6.8 2.3
Botulism 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
Brucellosis 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.01
Campylobacteriosis 22.4 30.4 11.9 9.5 10.1 13.3 11.7 15.1 12.7 11.6 13.3
Chlamydia NA NA NA 60.5 1423.4 1132.9 220.9 41.7 11.6 2.1 303.1
Cryptosporidiosis 3.1 6.4 4.7 3.2 3.2 2.5 1.6 1.1 0.8 0.7 2.0
Cyclospora 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.3 0.05 0.1
Dengue Fever 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.10
E. Coli O157 0.0 1.0 2.4 1.1 1.3 0.8 0.2 0.2 0.4 0.4 0.7
EHEC** 4.6 3.6 0.9 0.6 1.1 0.8 0.2 0.3 0.3 0.7 0.7
Ehrlichiosis 0.0 0.4 0.9 0.6 1.4 1.0 2.4 3.7 4.3 5.4 2.9
Encephalitis (Non-Westnile) 1.5 0.2 5.0 0.0 0.4 0.1 0.5 0.4 0.3 0.9 0.4
Giardiasis 8.5 41.5 28.6 11.5 9.0 9.1 9.1 12.6 11.1 9.4 12.8
Gonorrhea NA NA NA 8.3 201.0 192.2 69.7 21.0 6.5 1.6 54.9
Haemophilus Influenzae 7.0 1.4 0.5 0.1 0.4 0.3 0.4 0.8 0.9 5.2 1.5
Hemolytic Uremic Syndrome 1.5 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.10 0.1
Hepatitis A 0.0 0.4 0.2 0.7 0.2 0.8 0.4 0.2 0.4 0.5 0.4
Hepatitis B - Acute 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.8 0.3 0.5
Hepatitis C - Acute 0.0 0.0 0.0 0.0 0.1 1.6 0.7 0.2 0.4 0.1 0.4
HIV*** 3.1 0.0 0.0 0.3 4.7 18.4 19.3 16.3 10.2 2.1 9.5
Laboratory Confirmed Influenza 1238.3 902.9 1209.6 998.7 554.4 300.3 211.8 164.2 120.2 62.7 358.2
Legionellosis 0.0 0.0 0.0 0.1 0.0 0.5 0.7 3.1 5.1 10.0 3.3
Listeriosis 3.9 0.4 0.0 0.1 0.0 0.3 0.2 0.1 0.6 2.2 0.7
Lymphogranuloma Venereum NA NA NA 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.05
Malaria 0.0 0.8 0.3 0.0 0.5 0.7 1.2 0.4 0.4 0.2 0.5
Meningitis Aseptic 66.5 3.0 3.4 5.2 4.3 4.3 6.3 3.4 2.3 2.3 4.4
Meningococcal 5.4 0.6 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.4 0.2
Meningitis Other Bact. And Unknown 7.7 0.0 0.5 0.6 0.6 0.2 0.5 0.8 0.7 0.7 0.6
Mumps 3.9 6.2 11.2 28.9 22.3 5.6 2.5 0.6 0.4 0.2 5.8
Pertussis 40.2 6.6 11.3 5.9 2.3 0.7 0.9 0.4 0.5 0.3 2.4
Q Fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.05 0.02
RMSF 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.1
Salmonellosis 51.8 33.6 15.0 11.3 10.1 11.5 10.5 10.0 9.9 10.5 12.3
Shigellosis 1.0 10.5 6.9 1.5 1.1 2.0 2.0 1.5 1.4 0.8 2.2
Staph. Enterotoxin B Poisoning 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.01
Strep Group A Invasive 8.5 3.0 2.3 0.7 0.5 1.0 1.4 1.9 2.6 8.2 3.0
Strep Group B Invasive 44.8 0.4 0.2 0.1 0.8 0.9 2.9 5.0 7.9 22.0 7.3
Strep Pneumonia Invasive***** 41.0 20.7 4.4 2.6 2.4 3.2 6.9 8.4 15.8 35.0 13.6
Syphilis Early NA NA NA 0.0 3.9 6.7 3.8 3.0 1.4 0.2 2.4
Syphilis Late NA NA NA 0.0 1.8 4.2 5.3 6.9 5.6 3.8 3.9
Toxic Shock Syndrome 0.8 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.7 0.4 0.20
Tuberculosis 3.9 1.8 0.5 0.1 1.2 3.1 3.3 1.8 1.5 3.4 2.2
Typhoid Fever 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.1 0.0 0.1
Vibrio - Non Cholera 0.0 0.0 0.2 0.3 0.4 0.2 0.3 0.6 0.6 1.1 0.5
VISA 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1
West Nile Fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.01
West Nile Virus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.04
Yersiniosis 3.1 0.6 0.6 0.4 0.1 0.3 0.2 0.3 0.3 0.6 0.4

Footnotes

  • * Based on report year (excludes inmates). Includes all newly-reported AIDS cases regardless of HIV diagnosis date. Provisional, data as of August 5, 2010. County of residence is unknown for 6 cases.
  • ** E.coli non-O157 and not sero-grouped shigatoxin producing infection
  • *** Based on report year (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis. Provisional, data as of August 5, 2010. County of residence is unknown for 16 cases.
  • ***** Resistant, Sensitive, Intermediate, & Unknown